Bengaluru: UK Trade & Investment (UKTI) and the Association of Biotech Led Enterprises (ABLE) signed a memorandum of understanding (MoU) to encourage and develop collaborative opportunities between Indian life sciences organisations and the UK, in Bangalore.
The MoU is a milestone for the UK Oncology Mission, which is on a tri-city tour (Mumbai, Bangalore and Chennai). The 12-member UK delegation comprises prominent members from universities, healthcare companies, cancer research organisations and healthcare providers such as diagnostics and drug delivery systems.
The MoU will aim at combining UK’s heritage and leadership in the area of healthcare and life sciences and India’s emerging healthcare ecosystem to promote and develop the sciences sector in both countries.
ABLE and UKTI also run the Core Initiative Groups in different sector strands in life sciences. The partnership will include the participation of UK and Indian experts in life sciences in the areas of industry, research and trade.
It will further promote the UK and India as each other’s partners of choice in life sciences such as drug discovery, bioinformatics, regenerative medicine, clinical research, agri-bio, oncology and regulation. This will be done through ongoing research and discussion and identifying areas of potential business opportunity that can be addressed by Indian and UK firms.
In Chennai, later this week, the delegation will participate in the all-India launch of Healthcare UK and the IBHI-Indo-UK oncology summit. The delegates will travel to Mumbai to participate in a conference on advanced drug delivery system in oncology medicine in India for improving cancer care beyond the metros.
No comments:
Post a Comment